BV100 Philippines Trial: Two Hospitals, Revised Timelines
Witfire Elite | Philippines Pharma Watch | BV100 Philippines trial The BV100 Philippines trial plan names two hospitals and a target of 20 participants.…
Witfire Coverage
Category: Philippines Pharma Watch
Nerandomilast Philippines: Three Hospitals Listed
Witfire Elite | Philippines Pharma Watch | Clinical Catalysts | Nerandomilast Philippines Nerandomilast Philippines trial plans now list three hospitals and a target of…
RENGEVITY-201 Trial: Pegrizeprument Takes On Tacrolimus
Witfire Elite | Clinical Catalysts | Trial Design Audit RENGEVITY-201 trial dosing has begun, Veloxis says, with the first participant now treated. The Phase…
Alevia-B: Pascual Lab’s Pain and Mobility Push
Witfire Elite | Philippines Pharma Watch | OTC Formulation Audit Alevia-B is receiving fresh coverage in the Philippines through PascualLab’s 80th-anniversary portfolio campaign. Each…
Philippine FDA CPR Renewal Rule: Advisory 2026-1007
Witfire Elite · FDA & Regulatory Intelligence · Philippines Pharma Watch The FDA CPR renewal rule is narrower than a general grace period. A…
Philippines AI Liver Cancer Breakthrough: How the CANDLE Study Could Change Early Detection
Witfire Elite Philippines Pharma Watch Case Studies Strategy Breaking Analysis Philippines Pharma Watch Witfire Elite View Philippines AI Liver Cancer Breakthrough How the CANDLE…